StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.81+0.01 (+1.06%)

Close on Nov 17, 2026Market cap $104.43MP/E –Yield –

Organogenesis total assets

Total assets on the balance sheet at the end of each period.

Organogenesis's total assets was $406.45M at Jun 30, 2026. For fiscal 2025 it was $598.73M, up 20.3% from the year before. Over ten years it grew 106.9% a year on average. The highest annual figure on record is $598.73M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$598.73M+20.3%
FY2024Dec 31, 2024$497.89M+8.2%
FY2023Dec 31, 2023$460.03M+2.4%
FY2022Dec 31, 2022$449.36M+1.4%
FY2021Dec 31, 2021$443.26M+52.7%
FY2020Dec 31, 2020$290.22M+31.5%
FY2019Dec 31, 2019$220.69M+34.8%
FY2018Dec 31, 2018$163.68M+10.1%
FY2017Dec 31, 2017$148.72M-52.2%
FY2016Dec 31, 2016$311.44M+74715.7%
FY2015Dec 31, 2015$416.27K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$406.45M-11.9%
Q1 FY2026Mar 31, 2026$519.99M+11.3%
Q4 FY2025Dec 31, 2025$598.73M+20.3%
Q3 FY2025Sep 30, 2025$509.83M+14.2%
Q2 FY2025Jun 30, 2025$461.13M+4.1%
Q1 FY2025Mar 31, 2025$467.39M+1.9%
Q4 FY2024Dec 31, 2024$497.89M+8.2%
Q3 FY2024Sep 30, 2024$446.30M-3.5%
Q2 FY2024Jun 30, 2024$443.16M-1.6%
Q1 FY2024Mar 31, 2024$458.48M+2.8%
Q4 FY2023Dec 31, 2023$460.03M+2.4%
Q3 FY2023Sep 30, 2023$462.65M+1.2%
Q2 FY2023Jun 30, 2023$450.31M-1.3%
Q1 FY2023Mar 31, 2023$446.11M+2.3%
Q4 FY2022Dec 31, 2022$449.36M+1.4%
Q3 FY2022Sep 30, 2022$457.27M+23.4%
Q2 FY2022Jun 30, 2022$456.36M+28.3%
Q1 FY2022Mar 31, 2022$436.27M+36.7%
Q4 FY2021Dec 31, 2021$443.26M+52.7%
Q3 FY2021Sep 30, 2021$370.42M+50.3%
Q2 FY2021Jun 30, 2021$355.56M+64.2%
Q1 FY2021Mar 31, 2021$319.18M+53.2%
Q4 FY2020Dec 31, 2020$290.22M+31.5%
Q3 FY2020Sep 30, 2020$246.43M+41.1%
Q2 FY2020Jun 30, 2020$216.49M+28.8%
Q1 FY2020Mar 31, 2020$208.34M+18.1%
Q4 FY2019Dec 31, 2019$220.69M+34.8%
Q3 FY2019Sep 30, 2019$174.64M-44.8%
Q2 FY2019Jun 30, 2019$168.07M-46.6%
Q1 FY2019Mar 31, 2019$176.45M-43.8%
Q4 FY2018Dec 31, 2018$163.68M+10.1%
Q3 FY2018Sep 30, 2018$316.31M+1.4%
Q2 FY2018Jun 30, 2018$314.98M+1.1%
Q1 FY2018Mar 31, 2018$313.79M+0.8%
Q4 FY2017Dec 31, 2017$148.72M-52.2%
Q3 FY2017Sep 30, 2017$312.06M+37868.8%
Q2 FY2017Jun 30, 2017$311.56M–
Q1 FY2017Mar 31, 2017$311.24M–
Q4 FY2016Dec 31, 2016$311.44M–
Q3 FY2016Sep 30, 2016$821.88K–

More Organogenesis figures

See a number that looks wrong?